Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019
March 29, 2021
News
This narrative review from JAMA Neurology summarize available information regarding coronaviruses in the nervous system, identify the potential tissue targets and routes of entry of SARS-CoV-2 into the central nervous system, and describe the range of…
Zolgensma Benefits Observed in Presymptomatic SMA Patients
March 28, 2021
News
According to research presented at the 2021 Muscular Dystrophy Association (MDA) Virtual Clinical and Scientific Conference, on the SPR1NT trial Children with SMA treated with onasemnogene abeparvovec-xioi (Zolgensma®; Novartis) prior to the onset of…
Non-pharmacological options for Migraine in children
March 21, 2021
News
"Cell Polarity" gene mutations in Tourette disorder
March 20, 2021
News
In the largest DNA sequencing study of Tourette Disorder (TD) to date, UC San Francisco researchers and their collaborators have unearthed new data suggesting a potential role for disruptions in cell polarity in the development of this condition. The…
Mitochondrial defects may lead to Autism Spectrum Disorder
March 20, 2021
News
Researchers at Children's Hospital of Philadelphia (CHOP) have demonstrated that autism spectrum disorder (ASD) may be caused by defects in the mitochondria of brain cells. The findings were published online by the Proceedings of the National Academy of…
Jan 21, 2021
Jan 01, 2021
Oct 30, 2020
Sep 23, 2020
Sep 21, 2020
Sep 15, 2020
Sep 09, 2020
Aug 03, 2020
Jul 12, 2020
Jul 06, 2020
Kenneth F. Swaiman, MD [1931 - 2020]
1808 Hits
BPNA Annual Conference 2021
2159 Hits
Paul Casaer (1940 - 2020)
1991 Hits
14th EPNS Congress
1508 Hits
Pinned Items
Recent Activities
-
Elyssa Majawit added Update on Neuromuscular Disorders to favorites
SUMMARY1. "Hazardous neuromuscular diseases" Part 1: the malignant hyperthermia story and RYR1 mutations - implications to practice - Heinz JungbluthPart 2: More metabolic / hazardous neuromuscular diseases ie...More
SUMMARY1. "Hazardous neuromuscular diseases" Part 1: the malignant hyperthermia story and RYR1 mutations - implications to practice - Heinz JungbluthPart 2: More metabolic / hazardous neuromuscular diseases ie rhabdomyolysis - Ros Quinlivan2. Latest in therapies for key neuromuscular disorders - Professor Carsten Bonneman3. Standards of care for SMA and DMD - Dr Jo Wilmshurst… Read MorePost is under moderationStream item published successfully. Item will now be visible on your stream. -
Ingrid Lacerda Pessoa added Update on Neuromuscular Disorders to favorites
SUMMARY1. "Hazardous neuromuscular diseases" Part 1: the malignant hyperthermia story and RYR1 mutations - implications to practice - Heinz JungbluthPart 2: More metabolic / hazardous neuromuscular diseases ie...More
SUMMARY1. "Hazardous neuromuscular diseases" Part 1: the malignant hyperthermia story and RYR1 mutations - implications to practice - Heinz JungbluthPart 2: More metabolic / hazardous neuromuscular diseases ie rhabdomyolysis - Ros Quinlivan2. Latest in therapies for key neuromuscular disorders - Professor Carsten Bonneman3. Standards of care for SMA and DMD - Dr Jo Wilmshurst… Read MorePost is under moderationStream item published successfully. Item will now be visible on your stream. -
Ingrid Lacerda Pessoa added Monoclonal antibodies in Multiple Sclerosis to favorites
The following table essentially highlights the relative efficacies of MS therapies. And you can see that the top four treatments, which are all monoclonal antibodies,...More
The following table essentially highlights the relative efficacies of MS therapies. And you can see that the top four treatments, which are all monoclonal antibodies, have a higher efficacy. What you have to appreciate is most of these treatments have been tested against active comparators; therefore, the relative efficacy is much higher th… Read MorePost is under moderationStream item published successfully. Item will now be visible on your stream. -
Ingrid Lacerda Pessoa added Practical Paediatric Neuroradiology to favoritesPost is under moderationStream item published successfully. Item will now be visible on your stream.
-
May 22, 2021Pediatric MS, MOGAD and NMOSD : Similarities and DifferencesSylvia Tenembaum (National Paediatric Hospital Dr. Juan P. Garrahan, Argentina) {slider title="About the speaker"...More
May 22, 2021Pediatric MS, MOGAD and NMOSD : Similarities and DifferencesSylvia Tenembaum (National Paediatric Hospital Dr. Juan P. Garrahan, Argentina) {slider title="About the speaker" open="false" scroll="false" class="icon"} Dr Silvia Tenembaum is a pediatric neurologist who received her MD with honours, from the School of Medicine, University o… Read MorePost is under moderationStream item published successfully. Item will now be visible on your stream.
There are no activities here yet
